Webcasts of Satellite Symposium from ESMO 2016
European Society for Medical Oncology
Progress in the treatment of advanced breast cancer: spotlight on selective CDK4&6 inhibitors
CDK inhibitors are emerging as a powerful treatment for advanced breast cancer. Progress in these treatments was discussed by a distinguished faculty of experts at a satellite symposium at this year’s ESMO congress, and the discussions, along with an interview with distinguished Chair of the symposium, Fatima Cardoso, are now available for you to view as a series of webcasts. Topics covered in the highly interactive symposium are:
- The mechanisms underlying CDK4&6 inhibition
- The rationale for using CDK4&6 inhibitors to treat advanced breast cancer
- The clinical data supporting the use of CDK4&6 inhibitors in the treatment of advanced breast cancer.